AGIO

#1742
Agios Pharmaceuticals, Inc. - Common Stock
29.4 0 USD
-3.35%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
29.38
29.40
년간 변동
0.28
45.99
일일 변동
-3.35%
월간 변동
+4.74%
6달 변화
+3.12%
년간 변동율
-32.24%
이전 종가
30.4 2
Open
29.3 8
저가
29.3 8
High
29.4 0
양
121
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 1.75 B
  • Employee 540
  • Founded 2008
  • CEO N/A
  • Website www.agios.com
  • Headquarter Delaware, United States
  • FIGI BBG000QY4ZD0
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-3.82
주가매출액비율
29.21

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

뉴스